Revvity | PKI - Ativos





Ativos Alterar Data
Agilent USD 13.97B 902M 2026-06
Align Technology USD 6.42B 103.41M 2026-06
Bio Techne USD 2.59B 36.12M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Celltrion KRW 768.81B 9.37B 2026-03
Charles River Laboratories USD 7.53B 198.16M 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Illumina USD 6.65B 91M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 18.53B 554.8M 2026-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
OraSure Technologies USD 360.55M 18.62M 2026-06
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pacific Biosciences Of California USD 751.85M 30.51M 2026-06
Pharma Mar EUR 393.6M 8.34M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Tilray USD 2.1B 15.95M 2025-09
Waters USD 24.75B 220M 2026-06
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.51B 129.02M 2026-06